Global GLP-1 Agonist Supply, Demand and Key Producers, 2023-2029
Page: 102
Published Date: 02 Jun 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global GLP-1 Agonist market size is expected to reach $ 59500 million by 2029, rising at a market growth of 15.9% CAGR during the forecast period (2023-2029).
GLP-1 is a polypeptide hormone secreted by the intestine after being stimulated by food. It can stimulate the pancreatic beta cells to secrete insulin and participate in the regulation of blood sugar balance in the human body. However, natural GLP-1 is easily degraded by dipeptidyl peptidase in vivo and loses its activity. In order to make GLP-1 better for clinical application, drug developers have modified its structure and developed a series of GLP-1 receptor agonists. GLP-1 receptor agonists can exert the same biological effects as natural GLP-1, and can also avoid being degraded and inactivated, thereby prolonging the action time.
This report studies the global GLP-1 Agonist production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GLP-1 Agonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Agonist that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GLP-1 Agonist total production and demand, 2018-2029, (K Units)
Global GLP-1 Agonist total production value, 2018-2029, (USD Million)
Global GLP-1 Agonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GLP-1 Agonist consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: GLP-1 Agonist domestic production, consumption, key domestic manufacturers and share
Global GLP-1 Agonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global GLP-1 Agonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GLP-1 Agonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global GLP-1 Agonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Sanofi, GSK, Eli Lilly, Zealand Pharma A/S, hansoh and BENEMAE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Agonist market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GLP-1 Agonist Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global GLP-1 Agonist Market, Segmentation by Type
Long-Acting Drug
Short-Acting Drug
Global GLP-1 Agonist Market, Segmentation by Application
Diabetes
Obesity
Nonalcoholic Fatty Liver Disease
Metabolic Disorder
Alzheimer's Disease
Other
Companies Profiled:
Novo Nordisk
AstraZeneca
Sanofi
GSK
Eli Lilly
Zealand Pharma A/S
hansoh
BENEMAE
Key Questions Answered
1. How big is the global GLP-1 Agonist market?
2. What is the demand of the global GLP-1 Agonist market?
3. What is the year over year growth of the global GLP-1 Agonist market?
4. What is the production and production value of the global GLP-1 Agonist market?
5. Who are the key producers in the global GLP-1 Agonist market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 GLP-1 Agonist Introduction
1.2 World GLP-1 Agonist Supply & Forecast
1.2.1 World GLP-1 Agonist Production Value (2018 & 2022 & 2029)
1.2.2 World GLP-1 Agonist Production (2018-2029)
1.2.3 World GLP-1 Agonist Pricing Trends (2018-2029)
1.3 World GLP-1 Agonist Production by Region (Based on Production Site)
1.3.1 World GLP-1 Agonist Production Value by Region (2018-2029)
1.3.2 World GLP-1 Agonist Production by Region (2018-2029)
1.3.3 World GLP-1 Agonist Average Price by Region (2018-2029)
1.3.4 North America GLP-1 Agonist Production (2018-2029)
1.3.5 Europe GLP-1 Agonist Production (2018-2029)
1.3.6 China GLP-1 Agonist Production (2018-2029)
1.3.7 Japan GLP-1 Agonist Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GLP-1 Agonist Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GLP-1 Agonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World GLP-1 Agonist Demand (2018-2029)
2.2 World GLP-1 Agonist Consumption by Region
2.2.1 World GLP-1 Agonist Consumption by Region (2018-2023)
2.2.2 World GLP-1 Agonist Consumption Forecast by Region (2024-2029)
2.3 United States GLP-1 Agonist Consumption (2018-2029)
2.4 China GLP-1 Agonist Consumption (2018-2029)
2.5 Europe GLP-1 Agonist Consumption (2018-2029)
2.6 Japan GLP-1 Agonist Consumption (2018-2029)
2.7 South Korea GLP-1 Agonist Consumption (2018-2029)
2.8 ASEAN GLP-1 Agonist Consumption (2018-2029)
2.9 India GLP-1 Agonist Consumption (2018-2029)
3.1 World GLP-1 Agonist Production Value by Manufacturer (2018-2023)
3.2 World GLP-1 Agonist Production by Manufacturer (2018-2023)
3.3 World GLP-1 Agonist Average Price by Manufacturer (2018-2023)
3.4 GLP-1 Agonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GLP-1 Agonist Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GLP-1 Agonist in 2022
3.5.3 Global Concentration Ratios (CR8) for GLP-1 Agonist in 2022
3.6 GLP-1 Agonist Market: Overall Company Footprint Analysis
3.6.1 GLP-1 Agonist Market: Region Footprint
3.6.2 GLP-1 Agonist Market: Company Product Type Footprint
3.6.3 GLP-1 Agonist Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: GLP-1 Agonist Production Value Comparison
4.1.1 United States VS China: GLP-1 Agonist Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GLP-1 Agonist Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GLP-1 Agonist Production Comparison
4.2.1 United States VS China: GLP-1 Agonist Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GLP-1 Agonist Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GLP-1 Agonist Consumption Comparison
4.3.1 United States VS China: GLP-1 Agonist Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GLP-1 Agonist Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GLP-1 Agonist Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GLP-1 Agonist Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GLP-1 Agonist Production Value (2018-2023)
4.4.3 United States Based Manufacturers GLP-1 Agonist Production (2018-2023)
4.5 China Based GLP-1 Agonist Manufacturers and Market Share
4.5.1 China Based GLP-1 Agonist Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GLP-1 Agonist Production Value (2018-2023)
4.5.3 China Based Manufacturers GLP-1 Agonist Production (2018-2023)
4.6 Rest of World Based GLP-1 Agonist Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GLP-1 Agonist Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GLP-1 Agonist Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GLP-1 Agonist Production (2018-2023)
5.1 World GLP-1 Agonist Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Long-Acting Drug
5.2.2 Short-Acting Drug
5.3 Market Segment by Type
5.3.1 World GLP-1 Agonist Production by Type (2018-2029)
5.3.2 World GLP-1 Agonist Production Value by Type (2018-2029)
5.3.3 World GLP-1 Agonist Average Price by Type (2018-2029)
6.1 World GLP-1 Agonist Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diabetes
6.2.2 Obesity
6.2.3 Nonalcoholic Fatty Liver Disease
6.2.4 Metabolic Disorder
6.2.5 Alzheimer's Disease
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World GLP-1 Agonist Production by Application (2018-2029)
6.3.2 World GLP-1 Agonist Production Value by Application (2018-2029)
6.3.3 World GLP-1 Agonist Average Price by Application (2018-2029)
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk GLP-1 Agonist Product and Services
7.1.4 Novo Nordisk GLP-1 Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca GLP-1 Agonist Product and Services
7.2.4 AstraZeneca GLP-1 Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi GLP-1 Agonist Product and Services
7.3.4 Sanofi GLP-1 Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 GSK
7.4.1 GSK Details
7.4.2 GSK Major Business
7.4.3 GSK GLP-1 Agonist Product and Services
7.4.4 GSK GLP-1 Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 GSK Recent Developments/Updates
7.4.6 GSK Competitive Strengths & Weaknesses
7.5 Eli Lilly
7.5.1 Eli Lilly Details
7.5.2 Eli Lilly Major Business
7.5.3 Eli Lilly GLP-1 Agonist Product and Services
7.5.4 Eli Lilly GLP-1 Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly Recent Developments/Updates
7.5.6 Eli Lilly Competitive Strengths & Weaknesses
7.6 Zealand Pharma A/S
7.6.1 Zealand Pharma A/S Details
7.6.2 Zealand Pharma A/S Major Business
7.6.3 Zealand Pharma A/S GLP-1 Agonist Product and Services
7.6.4 Zealand Pharma A/S GLP-1 Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Zealand Pharma A/S Recent Developments/Updates
7.6.6 Zealand Pharma A/S Competitive Strengths & Weaknesses
7.7 hansoh
7.7.1 hansoh Details
7.7.2 hansoh Major Business
7.7.3 hansoh GLP-1 Agonist Product and Services
7.7.4 hansoh GLP-1 Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 hansoh Recent Developments/Updates
7.7.6 hansoh Competitive Strengths & Weaknesses
7.8 BENEMAE
7.8.1 BENEMAE Details
7.8.2 BENEMAE Major Business
7.8.3 BENEMAE GLP-1 Agonist Product and Services
7.8.4 BENEMAE GLP-1 Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 BENEMAE Recent Developments/Updates
7.8.6 BENEMAE Competitive Strengths & Weaknesses
8.1 GLP-1 Agonist Industry Chain
8.2 GLP-1 Agonist Upstream Analysis
8.2.1 GLP-1 Agonist Core Raw Materials
8.2.2 Main Manufacturers of GLP-1 Agonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GLP-1 Agonist Production Mode
8.6 GLP-1 Agonist Procurement Model
8.7 GLP-1 Agonist Industry Sales Model and Sales Channels
8.7.1 GLP-1 Agonist Sales Model
8.7.2 GLP-1 Agonist Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World GLP-1 Agonist Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GLP-1 Agonist Production Value by Region (2018-2023) & (USD Million)
Table 3. World GLP-1 Agonist Production Value by Region (2024-2029) & (USD Million)
Table 4. World GLP-1 Agonist Production Value Market Share by Region (2018-2023)
Table 5. World GLP-1 Agonist Production Value Market Share by Region (2024-2029)
Table 6. World GLP-1 Agonist Production by Region (2018-2023) & (K Units)
Table 7. World GLP-1 Agonist Production by Region (2024-2029) & (K Units)
Table 8. World GLP-1 Agonist Production Market Share by Region (2018-2023)
Table 9. World GLP-1 Agonist Production Market Share by Region (2024-2029)
Table 10. World GLP-1 Agonist Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World GLP-1 Agonist Average Price by Region (2024-2029) & (US$/Unit)
Table 12. GLP-1 Agonist Major Market Trends
Table 13. World GLP-1 Agonist Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World GLP-1 Agonist Consumption by Region (2018-2023) & (K Units)
Table 15. World GLP-1 Agonist Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World GLP-1 Agonist Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GLP-1 Agonist Producers in 2022
Table 18. World GLP-1 Agonist Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key GLP-1 Agonist Producers in 2022
Table 20. World GLP-1 Agonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global GLP-1 Agonist Company Evaluation Quadrant
Table 22. World GLP-1 Agonist Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GLP-1 Agonist Production Site of Key Manufacturer
Table 24. GLP-1 Agonist Market: Company Product Type Footprint
Table 25. GLP-1 Agonist Market: Company Product Application Footprint
Table 26. GLP-1 Agonist Competitive Factors
Table 27. GLP-1 Agonist New Entrant and Capacity Expansion Plans
Table 28. GLP-1 Agonist Mergers & Acquisitions Activity
Table 29. United States VS China GLP-1 Agonist Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GLP-1 Agonist Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China GLP-1 Agonist Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based GLP-1 Agonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GLP-1 Agonist Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GLP-1 Agonist Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GLP-1 Agonist Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers GLP-1 Agonist Production Market Share (2018-2023)
Table 37. China Based GLP-1 Agonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GLP-1 Agonist Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GLP-1 Agonist Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GLP-1 Agonist Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers GLP-1 Agonist Production Market Share (2018-2023)
Table 42. Rest of World Based GLP-1 Agonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GLP-1 Agonist Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GLP-1 Agonist Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GLP-1 Agonist Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers GLP-1 Agonist Production Market Share (2018-2023)
Table 47. World GLP-1 Agonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GLP-1 Agonist Production by Type (2018-2023) & (K Units)
Table 49. World GLP-1 Agonist Production by Type (2024-2029) & (K Units)
Table 50. World GLP-1 Agonist Production Value by Type (2018-2023) & (USD Million)
Table 51. World GLP-1 Agonist Production Value by Type (2024-2029) & (USD Million)
Table 52. World GLP-1 Agonist Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World GLP-1 Agonist Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World GLP-1 Agonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GLP-1 Agonist Production by Application (2018-2023) & (K Units)
Table 56. World GLP-1 Agonist Production by Application (2024-2029) & (K Units)
Table 57. World GLP-1 Agonist Production Value by Application (2018-2023) & (USD Million)
Table 58. World GLP-1 Agonist Production Value by Application (2024-2029) & (USD Million)
Table 59. World GLP-1 Agonist Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World GLP-1 Agonist Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk GLP-1 Agonist Product and Services
Table 64. Novo Nordisk GLP-1 Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca GLP-1 Agonist Product and Services
Table 70. AstraZeneca GLP-1 Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi GLP-1 Agonist Product and Services
Table 76. Sanofi GLP-1 Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. GSK Basic Information, Manufacturing Base and Competitors
Table 80. GSK Major Business
Table 81. GSK GLP-1 Agonist Product and Services
Table 82. GSK GLP-1 Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. GSK Recent Developments/Updates
Table 84. GSK Competitive Strengths & Weaknesses
Table 85. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 86. Eli Lilly Major Business
Table 87. Eli Lilly GLP-1 Agonist Product and Services
Table 88. Eli Lilly GLP-1 Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Eli Lilly Competitive Strengths & Weaknesses
Table 91. Zealand Pharma A/S Basic Information, Manufacturing Base and Competitors
Table 92. Zealand Pharma A/S Major Business
Table 93. Zealand Pharma A/S GLP-1 Agonist Product and Services
Table 94. Zealand Pharma A/S GLP-1 Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Zealand Pharma A/S Recent Developments/Updates
Table 96. Zealand Pharma A/S Competitive Strengths & Weaknesses
Table 97. hansoh Basic Information, Manufacturing Base and Competitors
Table 98. hansoh Major Business
Table 99. hansoh GLP-1 Agonist Product and Services
Table 100. hansoh GLP-1 Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. hansoh Recent Developments/Updates
Table 102. BENEMAE Basic Information, Manufacturing Base and Competitors
Table 103. BENEMAE Major Business
Table 104. BENEMAE GLP-1 Agonist Product and Services
Table 105. BENEMAE GLP-1 Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of GLP-1 Agonist Upstream (Raw Materials)
Table 107. GLP-1 Agonist Typical Customers
Table 108. GLP-1 Agonist Typical Distributors
List of Figure
Figure 1. GLP-1 Agonist Picture
Figure 2. World GLP-1 Agonist Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GLP-1 Agonist Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GLP-1 Agonist Production (2018-2029) & (K Units)
Figure 5. World GLP-1 Agonist Average Price (2018-2029) & (US$/Unit)
Figure 6. World GLP-1 Agonist Production Value Market Share by Region (2018-2029)
Figure 7. World GLP-1 Agonist Production Market Share by Region (2018-2029)
Figure 8. North America GLP-1 Agonist Production (2018-2029) & (K Units)
Figure 9. Europe GLP-1 Agonist Production (2018-2029) & (K Units)
Figure 10. China GLP-1 Agonist Production (2018-2029) & (K Units)
Figure 11. Japan GLP-1 Agonist Production (2018-2029) & (K Units)
Figure 12. GLP-1 Agonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GLP-1 Agonist Consumption (2018-2029) & (K Units)
Figure 15. World GLP-1 Agonist Consumption Market Share by Region (2018-2029)
Figure 16. United States GLP-1 Agonist Consumption (2018-2029) & (K Units)
Figure 17. China GLP-1 Agonist Consumption (2018-2029) & (K Units)
Figure 18. Europe GLP-1 Agonist Consumption (2018-2029) & (K Units)
Figure 19. Japan GLP-1 Agonist Consumption (2018-2029) & (K Units)
Figure 20. South Korea GLP-1 Agonist Consumption (2018-2029) & (K Units)
Figure 21. ASEAN GLP-1 Agonist Consumption (2018-2029) & (K Units)
Figure 22. India GLP-1 Agonist Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of GLP-1 Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GLP-1 Agonist Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GLP-1 Agonist Markets in 2022
Figure 26. United States VS China: GLP-1 Agonist Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GLP-1 Agonist Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GLP-1 Agonist Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GLP-1 Agonist Production Market Share 2022
Figure 30. China Based Manufacturers GLP-1 Agonist Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GLP-1 Agonist Production Market Share 2022
Figure 32. World GLP-1 Agonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GLP-1 Agonist Production Value Market Share by Type in 2022
Figure 34. Long-Acting Drug
Figure 35. Short-Acting Drug
Figure 36. World GLP-1 Agonist Production Market Share by Type (2018-2029)
Figure 37. World GLP-1 Agonist Production Value Market Share by Type (2018-2029)
Figure 38. World GLP-1 Agonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World GLP-1 Agonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World GLP-1 Agonist Production Value Market Share by Application in 2022
Figure 41. Diabetes
Figure 42. Obesity
Figure 43. Nonalcoholic Fatty Liver Disease
Figure 44. Metabolic Disorder
Figure 45. Alzheimer's Disease
Figure 46. Other
Figure 47. World GLP-1 Agonist Production Market Share by Application (2018-2029)
Figure 48. World GLP-1 Agonist Production Value Market Share by Application (2018-2029)
Figure 49. World GLP-1 Agonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. GLP-1 Agonist Industry Chain
Figure 51. GLP-1 Agonist Procurement Model
Figure 52. GLP-1 Agonist Sales Model
Figure 53. GLP-1 Agonist Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novo Nordisk AstraZeneca Sanofi GSK Eli Lilly Zealand Pharma A/S hansoh BENEMAE
Related Reports
02 Jun 2023
Pharma & Healthcare
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
